The epidemic has eased, and the crowds of movie theaters have returned strongly! Hollywood blockbuster hits record at box office.
As countries around the world unblocked the epidemic, the crowds of movie theaters have returned strongly.
The film industry seems to be bidding farewell to the low ebb during the new crown pandemic, and related stocks have also been favored again and become the focus of market attention.
Recently, many Hollywood blockbusters have been released overseas.
The superhero movie “Venom 2” was released in North America on October 1, and the first weekend box office won a good score of 90.1 million US dollars.
In addition, James Bond’s 007 series of film “007: No Time to Die” was officially released in 54 markets around the world on September 30, with a box office of 119.1 million U.S. dollars in the first weekend.
“007: No Time to Die” became the first Hollywood movie to premiere over $100 million during the epidemic.
“007: No Time to Die” is scheduled to be released in the United States on October 8.
However, the rapid recovery of the global film industry has also pushed up the stock prices of a series of film stocks.
On Monday (October 4), when the US S&P 500 Index fell 1.3%, the share price of Ximanke, the second largest movie theater chain in the United States, rose 5.7% against the trend.
Cinema technology services company IMAX soared 4.52%, cinema operator Marcus Corp. closed up 2.90%, and film advertising company National CineMedia also rose 2.45%.
AMC, the nation’s largest movie theater chain, said that from Thursday to Sunday, approximately 3.9 million people flooded into all AMC theaters in the world.
This is a new high recorded over the weekend after the epidemic was unblocked and reopened.
This means that cinemas are gradually returning to their pre-epidemic levels.
International rating agencies have also re-assigned Ximanke, IMAX, Marcus and National Media “buy” ratings.